Neumarker
Founded 2022 · 20 employees on LinkedIn · 1 known investors
Find your way into Neumarker
Sign up to see every warm intro you have to Neumarker
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Neumarker team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Neumarker develops machine learning and biophysical tools to advance neuropsychiatric drug development and clinical care for CNS disorders. The company serves pharmaceutical and clinical organizations working on psychiatric and neurological treatments.
Founders & leadership
Neumarker was founded in 2022 by Ken Wang and Qiang Li.
Investors · 1
Foothill Ventureslisted by Foothill VenturesLos Altos · $100K – $10M
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Frequently asked questions
- What does Neumarker do?
- Neumarker develops machine learning and biophysical tools to advance neuropsychiatric drug development and clinical care for CNS disorders. The company serves pharmaceutical and clinical organizations working on psychiatric and neurological treatments.
- Who founded Neumarker?
- Neumarker was founded by Ken Wang, Qiang Li in 2022.
- Who are Neumarker's investors?
- Neumarker's investors include Foothill Ventures.



